Eden Research (LON:EDEN) Shares Up 10.4% – Here’s What Happened

Eden Research plc (LON:EDEN) shares shot up 10.4% during mid-day trading on Thursday . The company traded as high as GBX 2.74 and last traded at GBX 2.65. 561,808 shares traded hands during mid-day trading, an increase of 25% from the average session volume of 450,973 shares. The stock had previously closed at GBX 2.40.

Eden Research Price Performance

The company has a market cap of £14.56 million, a price-to-earnings ratio of -6.16 and a beta of 0.92. The company’s 50 day moving average price is GBX 2.37 and its 200 day moving average price is GBX 2.98. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.42 and a current ratio of 3.80.

Eden Research (LON:EDEN) last issued its quarterly earnings results on Wednesday, September 17th. The company reported GBX (0.25) earnings per share for the quarter. Eden Research had a negative net margin of 38.70% and a negative return on equity of 11.63%. On average, equities research analysts predict that Eden Research plc will post -66.0000038 earnings per share for the current fiscal year.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.